Inventor · disambiguated record
Jaehyun Eom
Also filed as: EOM JAEHYUN
4 granted patents·9 pending applications·3 citations·filing 2018–2024
61Inventor score
Top patents by PatentIndex Score
13 records- 0187US11707533B2Antibody-drug conjugate comprising antibody against human ROR1 and use for the sameLEGOCHEM BIOSCIENCES INC·Filed 2020·Granted Jul 25, 2023·2 cites·38 claims
- 0276US2025115670A1Bispecific antibody against alpha-syn/igf1r and use thereofABL BIO INC·Filed 2024·Application pending·0 cites
- 0373US12071483B1Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereofABL BIO INC·Filed 2018·Granted Aug 27, 2024·1 cites·18 claims
- 0471US2025066487A1Anti-egfr/anti-4-1bb bispecific antibody and use thereofABL BIO INC·Filed 2024·Application pending·0 cites
- 0570US2023357412A1Bispecific antibody against alpha-syn/igf1r and use thereofABL BIO INC·Filed 2022·Application pending·0 cites
- 0669US2023405139A1Antibody-drug conjugate comprising antibody against human ror1 and use for the sameLEGOCHEM BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0768US2024101687A1Bispecific Antibody to A-Syn/IGF1R and Use ThereofABL BIO INC·Filed 2023·Application pending·0 cites
- 0860US2022348665A1BISPECIFIC ANTIBODY AGAINST Alpha-SYN/IGF1R AND USE THEREOFABL BIO INC·Filed 2020·Application pending·0 cites
- 0960US2022380446A1Antibodies for treating alpha-synucleinopathiesABL BIO INCORPORATED·Filed 2022·Application pending·0 cites
- 1055US12168690B2Anti-EGFR/anti-4-1BB bispecific antibodyABL BIO INC·Filed 2020·Granted Dec 17, 2024·0 cites·6 claims
- 1146US2022125944A1Antibody-drug conjugate and use thereofABL BIO INC·Filed 2020·Application pending·0 cites
- 1243US12049493B2Anti-alpha-synuclein antibodies and uses thereofABL BIO INC·Filed 2018·Granted Jul 30, 2024·0 cites·20 claims
- 1340US2023279085A1ANTIBODIES TO alpha-SYNUCLEIN AND USES THEREOFABL BIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jaehyun Eom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →